Concourse Financial Group Securities’s Protagenic Therapeutics, Inc. Warrant PTIXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6270 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6955 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6947 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6961 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6960 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6889 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6730 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6572 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6340 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6346 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6167 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6117 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6000 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5971 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5801 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5609 |
|